Hexavest’s Novo Nordisk NVO Stock Holding History

Hexavest’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,100	Closed	-$28K	–	465
2019 Q3	$28K	Hold	1,100	–	–	﹤0.01%	365
2019 Q2	$28K	Hold	1,100	–	–	﹤0.01%	372
2019 Q1	$29K	Hold	1,100	–	–	﹤0.01%	343
2018 Q4	$25K	Hold	1,100	–	–	﹤0.01%	327
2018 Q3	$26K	Hold	1,100	–	–	﹤0.01%	373
2018 Q2	$25K	Hold	1,100	–	–	﹤0.01%	375
2018 Q1	$27K	Hold	1,100	–	–	﹤0.01%	410
2017 Q4	$30K	Hold	1,100	–	–	﹤0.01%	422
2017 Q3	$26K	Hold	1,100	–	–	﹤0.01%	428
2017 Q2	$24K	Hold	1,100	–	–	﹤0.01%	427
2017 Q1	$19K	Hold	1,100	–	–	﹤0.01%	441
2016 Q4	$20K	Hold	1,100	–	–	﹤0.01%	437
2016 Q3	$23K	Hold	1,100	–	–	﹤0.01%	429
2016 Q2	$30K	Hold	1,100	–	–	﹤0.01%	424
2016 Q1	$30K	Hold	1,100	–	–	﹤0.01%	413
2015 Q4	$32K	Hold	1,100	–	–	﹤0.01%	406
2015 Q3	$30K	Hold	1,100	–	–	﹤0.01%	402
2015 Q2	$30K	Hold	1,100	–	–	﹤0.01%	414
2015 Q1	$29K	Hold	1,100	–	–	﹤0.01%	402
2014 Q4	$23K	Hold	1,100	–	–	﹤0.01%	404
2014 Q3	$26K	Hold	1,100	–	–	﹤0.01%	406
2014 Q2	$25K	Hold	1,100	–	–	﹤0.01%	407
2014 Q1	$25K	Sell	1,100 -14,590	-93%	-$311K	﹤0.01%	403
2013 Q4	$290K	Hold	15,690	–	–	﹤0.01%	276
2013 Q3	$266K	Hold	15,690	–	–	﹤0.01%	282
2013 Q2	$243K	Buy	+15,690	New	+$261K	﹤0.01%	284

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Hexavest's NVO Position: Q4 2019 in Review

Hexavest sold out of Novo Nordisk (NVO) in Q4 2019, closing a stake of 1,100 shares — an estimated $28K sold.

Hexavest first reported a position in NVO in Q2 2013 and held it in 26 quarters. The position peaked at $290K in Q4 2013. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

Hexavest reported no remaining Novo Nordisk position as of Q4 2019 after selling out during the quarter.
Hexavest sold 1,100 Novo Nordisk shares in Q4 2019, an estimated $28K.
Hexavest first reported a position in Novo Nordisk in Q2 2013 and held it in 26 quarters.
Hexavest's Novo Nordisk position peaked at $290K in Q4 2013.
640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on Hexavest's 13F filing for Q4 2019, filed 9 Jan 2020.